Scribd Logo
Upload

Welcome to Scribd!

  • Potencial Q4

    Uploaded by

    Shirley Carranza
    10 views2 pages
    This medical report is for an 18-year-old female patient being treated for sensitive tuberculosis. [1] The patient began treatment in January 2021 but subsequent testing showed resistance to rifampicin. [2] Further sensitivity testing from June 2021 samples showed resistance to multiple first and second-line drugs. [3] A chest tomography from June 2021 showed signs of active lung disease. [4] While treatment failure is suspected due to positive cultures followed by negative results, the definition by the WHO has not been fully met so the patient may be eligible for a new treatment regimen.

    Original Description:

    Original Title

    POTENCIAL Q4

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This medical report is for an 18-year-old female patient being treated for sensitive tuberculosis. [1] The patient began treatment in January 2021 but subsequent testing showed resistance to rifampicin. [2] Further sensitivity testing from June 2021 samples showed resistance to multiple first and second-line drugs. [3] A chest tomography from June 2021 showed signs of active lung disease. [4] While treatment failure is suspected due to positive cultures followed by negative results, the definition by the WHO has not been fully met so the patient may be eligible for a new treatment regimen.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    10 views2 pages

    Potencial Q4

    Uploaded by

    Shirley Carranza
    This medical report is for an 18-year-old female patient being treated for sensitive tuberculosis. [1] The patient began treatment in January 2021 but subsequent testing showed resistance to rifampicin. [2] Further sensitivity testing from June 2021 samples showed resistance to multiple first and second-line drugs. [3] A chest tomography from June 2021 showed signs of active lung disease. [4] While treatment failure is suspected due to positive cultures followed by negative results, the definition by the WHO has not been fully met so the patient may be eligible for a new treatment regimen.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 2

    MEDICAL REPORT

    Age: 18 years old

    Starting weight: 54kg

    Gender: female

    Comorbidities: None

    Background: patient begins treatment at Social Security for sensitive TB with 2RHZE on
    01/11/2021; BK positive (++); passes to second phase on 03/12/2021 every other day with 4RH,
    regular treatment until 05/14/2021; GeneXpert results obtained 03/16/2021 resistant to
    Rifampicin (R).

    Restart treatment on 06/04/2021 with scheme: E/Z/Amk/Lfx/Eto/Cs (4th month) until 11/30/2021

    SENSITIVITY TEST:

    1. Sample collection date: 03/16/2021 PCR Result date: 03/24/2021 Resistant to R.


    2. Sample collection date: 06/10/2021 Genotype Result date: 07/16/2021 Resistant to
    R/H.
    3. Sample collection date: 06/10/2021 Genotype 2nd line Result date: 07/22/2021
    Resistant to Lfx/Mfx/Km/Cm
    4. Sample collection date: 06/10/2021 MGIT Result date: 07/22/2021 Resistant Amk/Cm
    / Contaminated Mfx/Lfx.
    5. Sample collection date: 06/10/2021 MGIT Result date: 08/10/2021 Resistant Amk/Cm
    / Contaminated Mfx/Lfx.
    6. Sample collection date: 06/10/2021 MGIT Result date: 09/10/2021 Resistant Mfx/
    Sensitive Lfx 1ug/Ml
    7. Sample collection date: 01/26/2022 Bacilloscopy – sputum Result date: 01/26/2022
    Negative.

    BACTERIOLOGICAL EVOLUTION:
    I. BK 06/2021 Direct (Negative); POSITIVE culture
    II. BK 07/2021 Direct (Negative); NEGATIVE Culture
    III. BK 08/2021 Direct (Negative); Crop IN PROCESS
    IV. BK 09/2021 Direct (Negative); Crop IN PROCESS
    V. BK 10/2021 Direct (Negative); Crop IN PROCESS
    VI. BK 11/2021 Direct (Negative); Crop IN PROCESS
    VII. BK 01/2022 Direct (Negative)
    THORAX TOMOGRAPHY REPORT WITHOUT CONTRAST 06/13/2021:

    Right lung shows parenchymal consolidation with bronchial dilations and cavitation located in
    segments II and III, adjacent to it tree-in-bud opacities and small nodular lesions are observed, the
    rest of lung parenchyma preserved.

    No pleural collections.

    In this particular case, treatment failure is suspected but not confirmed according to the WHO
    definition; has 1 Positive crop, then Negative; the rest pending, would the participant be eligible to
    start a new treatment regimen?

    You might also like